The biology of endotoxin

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 19, Issue 3, 2001, Pages 279-296

  Heine, H ^a   Rietschel, E Th ^a   Ulmer, A J ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Endotoxin; LPS; Toxic shock syndrome

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN;

B LYMPHOCYTE; CHEMICAL STRUCTURE; HEMATOPOIETIC STEM CELL; MACROPHAGE; MOLECULAR RECOGNITION; MONOCYTE; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PROTEIN INTERACTION; REVIEW; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANIMALS; BONE MARROW CELLS; ENDOTOXINS; HUMANS; LYMPHOCYTES; MICE;

EID: 0035173139     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:19:3:279     Document Type: Review

References (177)

1. Untersuchungen über das choleragift
2. Bacterial endotoxins
3. Bacterial endotoxin: Molecular relationships of structure to activity and function
4. Molecular mechanisms of endotoxin activity
5. The epidemiology of bacterial sepsis
6. Southwestern internal medicine conference: Septic shock
7. Tumor necrosis factor and host response to endotoxin
8. Interleukin-1
9. The biology of catechin/TNF. A primary mediator of the host response
10. LPS, recIL1 and smooth muscle cell-III activate vascular cells by specific mechanisms
11. Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes
12. Neutrophil CD14: Biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide
13. Lipopolysaccharides of gram-negative bacteria
14. Structure and biosynthesis of O-antigens
15. Polysaccharide antigens of Pseudomonas aeruginosa
16. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification
17. Newer aspects of the chemical structure and biological activity of bacterial endotoxins
18. Chemical structure of the core region of bacterial lipopolysaccharides
19. The chemistry and biological significance of 3-deoxy-2D-manno-2-octulosonic acid (kdo)
20. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides
21. New anticore LPS monoclonal antibodies with clinical potential
22. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides
23. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities
24. Total synthesis of Escherichia coli lipid A, the endotoxically active principle of cell-surface lipopolysaccharide
25. Chemical synthesis of lipid X and lipid Y, acylglucosamine-1-phosphates isolated from Escherichia coli mutants
26. Chemical structure and biologic activity of bacterial and synthetic lipid A
27. Bacterial endotoxins: Properties and structure of biologically active domains
28. Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures
29. Inhibition of interleukin-6 release and T-cell proliferation by synthetic mirror pseudo cord factor analogues in human peripheral blood mononuclear cells
30. Molecular aspects of the chemistry and biology of endotoxin
31. Induction of human interleukin 1 by bacterial and synthetic lipid A
32. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipo-polysaccharide in human whole blood ex vivo
33. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS
34. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice
35. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells
36. E5531, a pure endotoxin antagonist of high potency
37. Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A
38. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway
39. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway
40. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
41. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation
42. Structure-activity relationship of chemically synthesized nonreducing parts of lipid A analogs
43. Production of interleukin 1 from human monocytes stimulated by synthetic lipid A subunit analogues
44. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction
45. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A
46. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition
47. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells
48. Lipid Iva inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo
49. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes
50. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
51. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation
52. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide
53. Influence of the supramolecular structure of free lipid A on its biological activity
54. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages
55. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin
56. Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides
57. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils
58. Complementary DNA sequence of rabbit CAP18 - A unique lipopolysaccharide binding protein
59. Synthetic bactericidal peptide based on CAP37: A 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes
60. The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule
61. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions
62. Cellular responses to bacterial lipopolysaccharide: T cells recognize LPS determinants
63. Endotoxin-induced T lymphocyte proliferation
64. Effect of endotoxin on suppressor T cell function
65. The role of endothelial cells in inflammation
66. Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1
67. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6
68. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways
69. Production of cytokines by vascular cells - An update and implications for artherogenesis
70. Endothelium-derived modulators of leukocyte function
71. CD34(+) hematopoietic stem cells exert accessory function in lipopolysaccharide-induced T cell stimulation and CD80 expression on monocytes
72. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
73. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage
74. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice
75. Divergent response to LPS and bacteria in CD14-deficient murine macrophages
76. Structure and function of lipopolysaccharide binding protein
77. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
78. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice
79. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection
80. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin
81. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition
82. Soluble CD14 participates in the response of cells to lipopolysaccharide
83. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
84. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants
85. The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes
86. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14
87. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
88. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms
89. Toll-like receptors in the induction of the innate immune response
90. Toll signaling pathways in the innate immune response
91. The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults
92. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
93. Human toll-like receptor 2 confers responsiveness to bacterial LPS
94. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
95. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
96. Cutting edge: Cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin
97. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
98. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2
99. Toll-like receptor (TLR)-2 mediates treponema glycolipid and lipoteichoic acid (LTA)-induced NF-kappa B translocation
100. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
101. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
102. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
103. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2
104. MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4
105. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1
106. Cutting edge: Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
107. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: Transfer from CD14 to TLR4 and MD-2
108. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2
109. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism
110. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages
111. (-) cells
112. Heat shock protein 90 mediates macrophage activation by taxol and bacterial lipopolysaccharide
113. TREM-1 amplifies inflammation and is a crucial mediator of septic shock
114. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
115. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein
116. Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies
117. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide
118. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide
119. CD11/CD18 leukocyte integrins: New signaling receptors for bacterial endotoxin
120. Outside-in signaling by lipopolysaccharide through a tailless integrin
121. Multiple receptors for endotoxin
122. Recognition and plasma clearance of endotoxin by scavenger receptors
123. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains
124. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface
125. The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases
126. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn
127. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocyte-macrophage plasma membrane
128. Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14
129. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p561ck and p59fyn 1
130. Decay-accelerating factor functions as a signal transducing molecule for human T cells
131. Decay-accelerating factor functions as a signal transducing molecule for human monocytes
132. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases
133. Human Nod1 confers responsiveness to bacterial lipopolysaccharides
134. Genetic complexity of pathogen perception by plants: The example of Rcr3, a tomato gene required specifically by Cf-2
135. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF{kappa}B
136. + channel in transmembrane signaling
137. Lipopolysaccharide-induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction
138. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn
139. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes
140. Unresponsiveness of MyD88-deficient mice to endotoxin
141. Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide
142. Lipopolysaccharide response is linked to the GTP binding protein, Gi2, in the promonocytic cell line U937
143. Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages
144. Defective ceramide response in C3H/HeJ (Lpsd) macrophages
145. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells
146. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages
147. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages
148. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages
149. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages
150. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14
151. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
152. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway
153. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF- alpha genes
154. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
155. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
156. Inhibition of interleukin-1 beta production by SKF86002: Evidence of two sites of in vitro activity and of a time and system dependence
157. Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes
158. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes
159. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes
160. Bacterial lipopolysaccharide induces early and late activation of protein kinase C in inflammatory macrophages by selective activation of PKC-epsilon
161. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes
162. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages
163. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
164. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
165. NF-kappa B: Ten years after
166. Catalysis by a multiprotein IkappaB kinase complex
167. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
168. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway
169. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome activation and IkappaB proteolysis
170. Identification and characterization of an IkappaB kinase
171. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway
172. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction
173. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide
174. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages
175. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin